Conflict of Interest
Jennifer Doudna Disclosures
The Regents of the University of California have patents issued and pending for CRISPR technologies on which J.A.D. is an inventor.
J.A.D. is a cofounder of Azalea Theratupics, Caribou Biosciences, Editas Medicine, Evercrisp, Scribe Therapeutics, Intellia Therapeutics, and Mammoth Biosciences. J.A.D. is a scientific advisory board member at Evercrisp, Caribou Biosciences, Intellia Therapeutics, Scribe Therapeutics, Mammoth Biosciences, The Column Group and Inari. J.A.D. is Chief Science Advisor to Sixth Street, a Director at Johnson & Johnson, Altos and Tempus, and has a research project sponsored by Apple Tree Partners.
